March 20, 1979

This invention provides a new myotonolytic use of thiazoline, oxazoline and imidazoline derivatives and novel pharmaceutical compositions for such use.

6

March 20, 1979

05/898,558

April 21, 1978

514/249   514/907

A61K   31/425   (20060101)   A61K   31/42   (20060101)   A61K   31/495   (20060101)  

Apr 22, 1977 [GB] 16914/77 Apr 22, 1977 [GB] 16915/77

424/250  

4788209 - Antifungal 2-anilinothiazolines - Owned by Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH) Fungal infections of the skin and mucous membranes may be controlled by topical administration of a pharmaceutical composition comprising a N-(3- or 4-alkylphenyl)4,5-dihydro-2-thiazolamine.